- Published at
- by globenewswire.com
mixed
mixed
Cancer Biopsy Market to Reach USD 85.03 Billion by 2032, Driven by Rising Cancer Incidence and Advances in Liquid Biopsy Technologies
Increasing cases of cancer worldwide, investment in research and development, and continuous enhancement in biopsy technology are the factors responsible...